Literature DB >> 22966359

Role and mechanism of hypoxia-inducible factor-1 in cell growth and apoptosis of breast cancer cell line MDA-MB-231.

Yonghong Shi1, Miaomiao Chang, Fang Wang, Xiaohui Ouyang, Yongfeng Jia, Hua DU.   

Abstract

The role of hypoxia-inducible factor-1 (HIF-1) in tumor development and progression is well-established but its effect on tumor growth remains controversial. The present study investigated the effect of HIF-1 on tumor growth using the estrogen receptor-negative breast cancer cell line, MDA-MB-231. Using Western blotting, we detected a higher level of HIF-1α protein in MDA-MB-231 cells than in any other breast cancer cell lines analyzed, and this was accompanied by a more rapid growth pattern. Interruption of HIF-1α expression using small interference RNA (siRNA) significantly suppressed cell growth and increased apoptosis, but the cell cycle was not affected. Activated fragments with increased caspase 3 activity and a mobility shift of B cell lymphoma (Bcl-2) were also detected in cells treated with HIF-1α siRNA. HIF-1 allows breast cancer cells to grow under long-term serum deprivation by inactivation of the caspase cascade and thus inhibition of apoptosis. Blocking HIF-1α protein resulted in loss of Bcl-2 function, which may contribute to the activation of the caspase cascade.

Entities:  

Year:  2010        PMID: 22966359      PMCID: PMC3436333          DOI: 10.3892/ol_00000115

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Bafilomycin induces the p21-mediated growth inhibition of cancer cells under hypoxic conditions by expressing hypoxia-inducible factor-1alpha.

Authors:  Ji-Hong Lim; Jong-Wan Park; Myung-Suk Kim; Sang-Ki Park; Randall S Johnson; Yang-Sook Chun
Journal:  Mol Pharmacol       Date:  2006-08-28       Impact factor: 4.436

2.  Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death.

Authors:  M C Wei; W X Zong; E H Cheng; T Lindsten; V Panoutsakopoulou; A J Ross; K A Roth; G R MacGregor; C B Thompson; S J Korsmeyer
Journal:  Science       Date:  2001-04-27       Impact factor: 47.728

3.  In vitro study of HIF-1 activation and VEGF release by bFGF in the T47D breast cancer cell line under normoxic conditions: involvement of PI-3K/Akt and MEK1/ERK pathways.

Authors:  Yong-Hong Shi; Yu-Xiang Wang; Lynne Bingle; Li-Hua Gong; Wan-Jie Heng; Yan Li; Wei-Gang Fang
Journal:  J Pathol       Date:  2005-03       Impact factor: 7.996

Review 4.  HIF-1 and mechanisms of hypoxia sensing.

Authors:  G L Semenza
Journal:  Curr Opin Cell Biol       Date:  2001-04       Impact factor: 8.382

5.  Expression of phosphorylated Ser70 of Bcl-2 correlates with malignancy in human colorectal neoplasms.

Authors:  Eisaku Kondo; Takayoshi Miyake; Masao Shibata; Toshikazu Kimura; Hiromi Iwagaki; Shin-Ichi Nakamura; Takehiro Tanaka; Nobuya Ohara; Koichi Ichimura; Takashi Oka; Hiroyuki Yanai; Futoshi Shibasaki; Tadashi Yoshino
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

6.  Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo.

Authors:  David L Gillespie; Kum Whang; Brian T Ragel; Jeannette R Flynn; David A Kelly; Randy L Jensen
Journal:  Clin Cancer Res       Date:  2007-04-15       Impact factor: 12.531

7.  Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.

Authors:  Hiroshi Yoshimura; Dipok Kumar Dhar; Hitoshi Kohno; Hirofumi Kubota; Toshiyuki Fujii; Shuhei Ueda; Shoichi Kinugasa; Mitsuo Tachibana; Naofumi Nagasue
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

8.  Effects of hypoxia inducible factor-1alpha (HIF-1alpha) on the growth & adhesion in tongue squamous cell carcinoma cells.

Authors:  Ying Song; Wenxia Wang; Xun Qu; Shanzhen Sun
Journal:  Indian J Med Res       Date:  2009-02       Impact factor: 2.375

9.  Nuclear expression of hypoxia-inducible factor 1alpha protein is heterogeneous in human malignant cells under normoxic conditions.

Authors:  Hua Zhong; Nicola Mabjeesh; Margaret Willard; Jonathan Simons
Journal:  Cancer Lett       Date:  2002-07-26       Impact factor: 8.679

10.  Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.

Authors:  Ryosuke Osada; Akiko Horiuchi; Norihiko Kikuchi; Junko Yoshida; Akiko Hayashi; Masao Ota; Yoshihiko Katsuyama; Giovanni Melillo; Giovanni Mellilo; Ikuo Konishi
Journal:  Hum Pathol       Date:  2007-06-06       Impact factor: 3.466

View more
  9 in total

1.  HIF-1α acts as a molecular target for simvastatin cytotoxicity in B16.F10 melanoma cells cultured under chemically induced hypoxia.

Authors:  Emilia Licarete; Alina Sesarman; Valentin Florian Rauca; Lavinia Luput; Laura Patras; Manuela Banciu
Journal:  Oncol Lett       Date:  2017-03-27       Impact factor: 2.967

2.  HIFI-α activation underlies a functional switch in the paradoxical role of Ezh2/PRC2 in breast cancer.

Authors:  Sylvia Mahara; Puay Leng Lee; Min Feng; Vinay Tergaonkar; Wee Joo Chng; Qiang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-14       Impact factor: 11.205

3.  Role of hypoxia inducible factor 1α in cobalt nanoparticle induced cytotoxicity of human THP-1 macrophages.

Authors:  Wendy Rachel Francis; Zhao Liu; Sian E Owens; Xiao Wang; Huaming Xue; Alex Lord; Venkateswarlu Kanamarlapudi; Zhidao Xia
Journal:  Biomater Transl       Date:  2021-06-28

4.  Plumbagin Suppresses Breast Cancer Progression by Downregulating HIF-1α Expression via a PI3K/Akt/mTOR Independent Pathway under Hypoxic Condition.

Authors:  Supawan Jampasri; Somrudee Reabroi; Duangjai Tungmunnithum; Warisara Parichatikanond; Darawan Pinthong
Journal:  Molecules       Date:  2022-09-05       Impact factor: 4.927

5.  Oxygen-carbon nanotubes as a chemotherapy sensitizer for paclitaxel in breast cancer treatment.

Authors:  Yongkun Wang; Chuanying Wang; Yijun Jia; Xianhua Cheng; Qing Lin; Mingjie Zhu; Yunshu Lu; Longlong Ding; Ziyi Weng; Kejin Wu
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

6.  HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.

Authors:  Tariq Shah; Balaji Krishnamachary; Flonne Wildes; Yelena Mironchik; Samata M Kakkad; Desmond Jacob; Dmitri Artemov; Zaver M Bhujwalla
Journal:  Oncotarget       Date:  2015-09-29

7.  MicroRNA-101 targets von Hippel-Lindau tumor suppressor (VHL) to induce HIF1α mediated apoptosis and cell cycle arrest in normoxia condition.

Authors:  Ning Liu; Wu-Yan Xia; Shan-Shan Liu; Hai-Yan Chen; Lei Sun; Meng-Yao Liu; Lin-Feng Li; Hong-Min Lu; Yu-Jie Fu; Pei Wang; Hailong Wu; Jian-Xin Gao
Journal:  Sci Rep       Date:  2016-02-04       Impact factor: 4.379

8.  Intrinsic Disorder of the BAF Complex: Roles in Chromatin Remodeling and Disease Development.

Authors:  Nashwa El Hadidy; Vladimir N Uversky
Journal:  Int J Mol Sci       Date:  2019-10-23       Impact factor: 5.923

9.  A New Classification Method of Metastatic Cancers Using a 1H-NMR-Based Approach: A Study Case of Melanoma, Breast, and Prostate Cancer Cell Lines.

Authors:  Corentin Schepkens; Matthieu Dallons; Jonas Dehairs; Ali Talebi; Jérôme Jeandriens; Lise-Marie Drossart; Guillaume Auquier; Vanessa Tagliatti; Johannes V Swinnen; Jean-Marie Colet
Journal:  Metabolites       Date:  2019-11-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.